ArticleFrontiers in pharmacology2022

Elexacaftor-Tezacaftor-Ivacaftor Treatment Reduces Abdominal Symptoms in Cystic Fibrosis-Early results Obtained With the CF-Specific CFAbd-Score.

Jochen G Mainz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.